Search filters

Filters
Clear All

Phase

  • 1
  • 1
  • 3
  • 5
  • 1
  • 14
  • 25
  • 13
  • 25

Found 25 dm-pulmonary-allergy-and-critical-care trials

A listing of dm-pulmonary-allergy-and-critical-care medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
Adult Virome Study
99 years or below
Accepts healthy volunteer
All genders
Did you know that all of us, including all healthy people, have viruses in our bodies that do not make us sick but actually may contribute to health? Researchers are exploring the viruses that exist in people that are not currently sick in order to understand their role in human …
6 years or above
All genders
Phase 4
Interventional
This study investigates pulmonary exacerbations in people with cystic fibrosis. The purpose of this study is to compare the effects of different antibiotic treatments given through a tube into a vein.The study evaluates the effectiveness and safety of using one type of antibiotic versus two types in treating pulmonary exacerbations. …
18 years or above
All genders
Phase 3
Interventional
This study investigates progressive CLAD in individuals who have undergone bilateral lung transplantation. The purpose of this study is to evaluate the safety and effectiveness of an investigational medication in comparison to a placebo.The study focuses on assessing how well the investigational medication works and its safety in patients who …
18 years or above
All genders
Phase 2
Interventional
This study investigates an investigational gene therapy in adults with cystic fibrosis. The purpose of this study is to assess the safety, tolerability, and preliminary effectiveness of the investigational gene therapy for individuals who cannot use or tolerate CFTR modulator therapy.Participants in the study will receive a single dose of …
40 years or above
All genders
Phase 3
Interventional
The purpose of this study is to evaluate the effects of an investigational medication in people with idiopathic pulmonary fibrosis.This study focuses on assessing how safe and effective the investigational medication is for participants. It also looks at how well participants tolerate the treatment.Who can participate: Participants must be 40 …
18 years - 80 years
All genders
Phase 1/2
Interventional
This study investigates the feasibility and tolerability of an investigational medication in patients with advanced lung disease. Advanced lung diseases included in the study are interstitial lung disease, sarcoidosis, chronic obstructive pulmonary disease, and pulmonary hypertension. The purpose of this study is to assess whether patients can tolerate the investigational …
21 years or above
All genders
Phase 3
Interventional
This study investigates Progressive Pulmonary Fibrosis. The study focuses on understanding how the investigational medication works for this condition.This study evaluates the safety, effectiveness, and tolerability of the investigational medication. It looks into how well participants respond to the treatment.Who can participate: Adults diagnosed with interstitial lung disease (ILD) showing …
40 years - 80 years
All genders
This is a prospective, open-label, multi-center, single-arm study enrolling subjects with severe heterogeneous emphysema and collateral ventilation in the target lobe. Subjects will undergo instillation of AeriSeal Foam in the target lobe and subsequent assessment CV status using Chartis Pulmonary Assessment System. Subjects with CV- status will then undergo placement …
12 years or above
All genders
Observational
This study investigates cystic fibrosis (CF) in individuals who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators. The purpose of this study is to collect health data and specimens to support the development of treatments for people with CF who are not using CFTR modulators.Participants will be part …
18 years - 99 years
All genders
A Phase 2, randomized, open-label, active-controlled study of JNJ-90301900 in combination with chemoradiation followed by durvalumab in locally advanced and unresectable Stage III non-small cell lung cancer.
1 - 10 of 25